John Sununu’s Stance on National Debt Amidst Policy Contradictions
Republican John Sununu has emphasized his commitment to reducing the national debt as he campaigns for a U.S. Senate seat in New Hampshire. Despite these declarations, his historical support for certain policies has contributed to the increase of the national debt.
In a recent ad highlighting his Senate campaign, Sununu prioritized addressing the national deficit. He previously served in the Senate from 2003 to 2009 and has consistently underscored the need for economic growth, spending control, and deficit reduction.
“People definitely want to see us cut the deficit,” he stated in March, emphasizing the importance of making informed economic decisions each year.
However, Sununu backed the One Big Beautiful Bill Act (OBBB), a major tax reform that favors wealthy individuals and large corporations. He claimed that OBBB would decrease the deficit and downplayed opposing views as “liberal math.”
Contrary to his assertions, a Congressional Budget Office review indicates that OBBB is projected to increase the deficit by $3.4 trillion over ten years. Similarly, a Bipartisan Policy Center analysis predicts an addition of over $4 trillion to the national debt within the same timeframe, including interest expenses.
Sununu also endorsed the 2017 Tax Cuts and Jobs Act (TCJA), implemented under President Donald Trump. In a CNBC op-ed, he supported the act, stating it would enhance the competitiveness of American businesses.
The nonpartisan Tax Policy Center estimates that TCJA will add $1.5 trillion to the deficit by 2034.
Sununu’s financial interests extend to sectors benefiting from these laws, notably oil and gas. OBBB provided substantial subsidies to fossil fuel producers, and TCJA enabled expansion into the Arctic National Wildlife Refuge.
His investments include up to $50,000 in ExxonMobil and $65,000 in Shell.
Similarly, the pharmaceutical industry has seen favorable outcomes. OBBB excluded certain drugs from Medicare’s price negotiation program, compelling the government to pay an additional $5 billion to drug companies, according to the Congressional Budget Office.
Building on this, TCJA resulted in a collective tax reduction of $6 billion for the pharmaceutical sector.
Sununu has substantial holdings in pharmaceutical stocks and bonds, with up to $425,000 invested, including stakes in Pfizer and Merck.
During his tenure in the U.S. House of Representatives, Sununu supported the Economic Growth and Tax Relief Reconciliation Act and the Jobs and Growth Tax Relief Reconciliation Act, collectively known as the Bush tax cuts, which primarily benefited the top 1% of earners.
These policies were anticipated to increase the deficit by $1.7 trillion.
Sununu, endorsed by Trump, will compete against Democratic Rep. Chris Pappas in the upcoming November elections.
—
Read More Kitchen Table News
